Chapter 3. Vasculature, Vascular Disease, and Atherosclerosis

  1. Dr. Jean-Charles Sanchez,
  2. Dr. Garry L. Corthals,
  3. Prof. Dr. Denis F. Hochstrasser
  1. Elisabetta Gianazza1,
  2. Ivano Eberini2

Published Online: 20 SEP 2004

DOI: 10.1002/3527601562.ch3

Biomedical Applications of Proteomics

Biomedical Applications of Proteomics

How to Cite

Gianazza, E. and Eberini, I. (2004) Vasculature, Vascular Disease, and Atherosclerosis, in Biomedical Applications of Proteomics (eds J.-C. Sanchez, G. L. Corthals and D. F. Hochstrasser), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527601562.ch3

Editor Information

  1. Biomedical Proteomics Research Group, Laboratoire Central de Chimie Clinique, Hopitaux Universitaires de Genève, 24, rue Micheli-du-Crest, 1211 Genève 14, Switzerland

Author Information

  1. 1

    Gruppo di Studio per la Proteomica e la Struttura delle Proteine e Centro di Eccellenza sulle Malattie del Sistema Nervoso Centrale, e Periferico, Dipartimento di Scienze Farmacologiche, Via G. Balzaretti 9, 20133 Milano, Italy

  2. 2

    Gruppo di Studio per la Proteomica e la Struttura delle Proteine e Centro di Eccellenza sulle Malattie del Sistema Nervoso Centrale, e Periferico, Dipartimento di Scienze Farmacologiche, Università degli Studi di Milano, Via G. Balzaretti 9, 20133 Milano, Italy

Publication History

  1. Published Online: 20 SEP 2004
  2. Published Print: 27 JAN 2004

ISBN Information

Print ISBN: 9783527308071

Online ISBN: 9783527601561

SEARCH

Keywords:

  • vasculature;
  • vascular disease;
  • atherosclerosis;
  • lipoproteins;
  • apolipoproteins;
  • pathogenetic mechanisms;
  • surgical treatments;
  • pharmacology;
  • diet

Summary

  • Introduction

  • Protein Composition of Human Aorta in Atherosclerosis – Ex vivo Studies

    • Cellular Proteins

    • Infiltrating Proteins

  • Protein Composition of Human Aorta in Atherosclerosis – In vitro Studies

  • Lipoproteins and Apolipoproteins as Disease Factors

    • Typing of Apolipoprotein E Phenotype in Humans

    • Studies in Transgenic or Knockout Mice

  • Pathogenetic Mechanisms

  • End Pathologies: Myocardial and Cerebral Infarction

  • Surgical Treatments

  • Pharmacological and Dietary Treatments

  • Animal Models of Atherosclerosis and its Complications

  • Conclusions

  • Acknowledgements

  • References